• Je něco špatně v tomto záznamu ?

Antiviral activity of porphyrins and porphyrin-like compounds against tick-borne encephalitis virus: Blockage of the viral entry/fusion machinery by photosensitization-mediated destruction of the viral envelope

J. Holoubek, J. Salát, J. Kotouček, T. Kastl, M. Vancová, I. Huvarová, P. Bednář, K. Bednářová, D. Růžek, D. Renčiuk, L. Eyer

. 2024 ; 221 (-) : 105767. [pub] 20231130

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24007764

Tick-borne encephalitis virus (TBEV), the causative agent of tick-borne encephalitis (TBE), is a medically important flavivirus endemic to the European-Asian continent. Although more than 12,000 clinical cases are reported annually worldwide, there is no anti-TBEV therapy available to treat patients with TBE. Porphyrins are macrocyclic molecules consisting of a planar tetrapyrrolic ring that can coordinate a metal cation. In this study, we investigated the cytotoxicity and anti-TBEV activity of a large series of alkyl- or (het)aryl-substituted porphyrins, metalloporphyrins, and chlorins and characterized their molecular interactions with the viral envelope in detail. Our structure-activity relationship study showed that the tetrapyrrole ring is an essential structural element for anti-TBEV activity, but that the presence of different structurally distinct side chains with different lengths, charges, and rigidity or metal cation coordination can significantly alter the antiviral potency of porphyrin scaffolds. Porphyrins were demonstrated to interact with the TBEV lipid membrane and envelope protein E, disrupt the TBEV envelope and inhibit the TBEV entry/fusion machinery. The crucial mechanism of the anti-TBEV activity of porphyrins is based on photosensitization and the formation of highly reactive singlet oxygen. In addition to blocking viral entry and fusion, porphyrins were also observed to interact with RNA oligonucleotides derived from TBEV genomic RNA, indicating that these compounds could target multiple viral/cellular structures. Furthermore, immunization of mice with porphyrin-inactivated TBEV resulted in the formation of TBEV-neutralizing antibodies and protected the mice from TBEV infection. Porphyrins can thus be used to inactivate TBEV while retaining the immunogenic properties of the virus and could be useful for producing new inactivated TBEV vaccines.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24007764
003      
CZ-PrNML
005      
20240528105748.0
007      
ta
008      
240412e20231130ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.antiviral.2023.105767 $2 doi
035    __
$a (PubMed)38040199
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Holoubek, Jiří $u Laboratory of Emerging Viral Diseases, Veterinary Research Institute, CZ-62100, Brno, Czech Republic; Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, CZ-37005, Ceske Budejovice, Czech Republic; Department of Experimental Biology, Faculty of Science, Masaryk University, CZ-62500, Brno, Czech Republic
245    10
$a Antiviral activity of porphyrins and porphyrin-like compounds against tick-borne encephalitis virus: Blockage of the viral entry/fusion machinery by photosensitization-mediated destruction of the viral envelope / $c J. Holoubek, J. Salát, J. Kotouček, T. Kastl, M. Vancová, I. Huvarová, P. Bednář, K. Bednářová, D. Růžek, D. Renčiuk, L. Eyer
520    9_
$a Tick-borne encephalitis virus (TBEV), the causative agent of tick-borne encephalitis (TBE), is a medically important flavivirus endemic to the European-Asian continent. Although more than 12,000 clinical cases are reported annually worldwide, there is no anti-TBEV therapy available to treat patients with TBE. Porphyrins are macrocyclic molecules consisting of a planar tetrapyrrolic ring that can coordinate a metal cation. In this study, we investigated the cytotoxicity and anti-TBEV activity of a large series of alkyl- or (het)aryl-substituted porphyrins, metalloporphyrins, and chlorins and characterized their molecular interactions with the viral envelope in detail. Our structure-activity relationship study showed that the tetrapyrrole ring is an essential structural element for anti-TBEV activity, but that the presence of different structurally distinct side chains with different lengths, charges, and rigidity or metal cation coordination can significantly alter the antiviral potency of porphyrin scaffolds. Porphyrins were demonstrated to interact with the TBEV lipid membrane and envelope protein E, disrupt the TBEV envelope and inhibit the TBEV entry/fusion machinery. The crucial mechanism of the anti-TBEV activity of porphyrins is based on photosensitization and the formation of highly reactive singlet oxygen. In addition to blocking viral entry and fusion, porphyrins were also observed to interact with RNA oligonucleotides derived from TBEV genomic RNA, indicating that these compounds could target multiple viral/cellular structures. Furthermore, immunization of mice with porphyrin-inactivated TBEV resulted in the formation of TBEV-neutralizing antibodies and protected the mice from TBEV infection. Porphyrins can thus be used to inactivate TBEV while retaining the immunogenic properties of the virus and could be useful for producing new inactivated TBEV vaccines.
650    _2
$a lidé $7 D006801
650    _2
$a zvířata $7 D000818
650    _2
$a myši $7 D051379
650    12
$a viry klíšťové encefalitidy $x genetika $7 D004669
650    _2
$a protilátky virové $x terapeutické užití $7 D000914
650    _2
$a virový obal $7 D000086942
650    _2
$a internalizace viru $7 D053586
650    12
$a klíšťová encefalitida $7 D004675
650    12
$a porfyriny $x farmakologie $x terapeutické užití $7 D011166
650    _2
$a RNA $7 D012313
650    _2
$a antivirové látky $x farmakologie $x terapeutické užití $7 D000998
650    _2
$a kationty $x terapeutické užití $7 D002412
655    _2
$a časopisecké články $7 D016428
700    1_
$a Salát, Jiří $u Laboratory of Emerging Viral Diseases, Veterinary Research Institute, CZ-62100, Brno, Czech Republic; Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, CZ-37005, Ceske Budejovice, Czech Republic; Department of Experimental Biology, Faculty of Science, Masaryk University, CZ-62500, Brno, Czech Republic
700    1_
$a Kotouček, Jan $u Department of Pharmacology and Toxicology, Veterinary Research Institute, CZ-62100, Brno, Czech Republic
700    1_
$a Kastl, Tomáš $u Laboratory of Emerging Viral Diseases, Veterinary Research Institute, CZ-62100, Brno, Czech Republic
700    1_
$a Vancová, Marie $u Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, CZ-37005, Ceske Budejovice, Czech Republic; Faculty of Science, University of South Bohemia, CZ-37005, Ceske Budejovice, Czech Republic
700    1_
$a Huvarová, Ivana $u Laboratory of Emerging Viral Diseases, Veterinary Research Institute, CZ-62100, Brno, Czech Republic
700    1_
$a Bednář, Petr $u Laboratory of Emerging Viral Diseases, Veterinary Research Institute, CZ-62100, Brno, Czech Republic; Department of Experimental Biology, Faculty of Science, Masaryk University, CZ-62500, Brno, Czech Republic; Faculty of Science, University of South Bohemia, CZ-37005, Ceske Budejovice, Czech Republic
700    1_
$a Bednářová, Klára $u Department of Biophysics of Nucleic Acids, Institute of Biophysics of the Czech Academy of Sciences, CZ-61200, Brno, Czech Republic
700    1_
$a Růžek, Daniel, $d 1981- $u Laboratory of Emerging Viral Diseases, Veterinary Research Institute, CZ-62100, Brno, Czech Republic; Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, CZ-37005, Ceske Budejovice, Czech Republic; Department of Experimental Biology, Faculty of Science, Masaryk University, CZ-62500, Brno, Czech Republic $7 stk2008441707
700    1_
$a Renčiuk, Daniel $u Department of Biophysics of Nucleic Acids, Institute of Biophysics of the Czech Academy of Sciences, CZ-61200, Brno, Czech Republic
700    1_
$a Eyer, Luděk $u Laboratory of Emerging Viral Diseases, Veterinary Research Institute, CZ-62100, Brno, Czech Republic; Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, CZ-37005, Ceske Budejovice, Czech Republic; Department of Experimental Biology, Faculty of Science, Masaryk University, CZ-62500, Brno, Czech Republic. Electronic address: ludek.eyer@vri.cz
773    0_
$w MED00000480 $t Antiviral research $x 1872-9096 $g Roč. 221 (20231130), s. 105767
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38040199 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20240528105745 $b ABA008
999    __
$a ok $b bmc $g 2081633 $s 1217531
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 221 $c - $d 105767 $e 20231130 $i 1872-9096 $m Antiviral research $n Antiviral Res $x MED00000480
LZP    __
$a Pubmed-20240412

Najít záznam

Citační ukazatele

Možnosti archivace